Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3.

Tanja EichkornJonathan W LischalkJuliane Hörner-RieberMaximilian DengEva MeixnerAnna KrämerPhilipp HoegenElisabetta SandriniSebastian RegneryThomas HeldSemi HarrabiChristine JungkKlaus HerfarthJürgen DebusLaila König

Published in: Journal of neuro-oncology (2023)

These data demonstrate the effectiveness of PRT for IDH-mutated glioma WHO grade 2 and 3. The RICE risk differs with WHO grading and is higher in older patients with IDH-mutated Glioma WHO grade 2 and 3.

Keyphrases

wild type
low grade
randomized controlled trial
early stage
radiation therapy
physical activity
electronic health record
big data
squamous cell carcinoma
radiation induced
machine learning
artificial intelligence
rectal cancer
electron transfer